| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.18M | -1.25M | -12.29M | 100.00M | 186.25M | 9.19M |
| Gross Profit | 8.18M | -1.25M | -12.29M | 100.00M | 186.25M | 9.19M |
| EBITDA | -2.83M | -2.83M | -13.94M | 98.30M | 185.01M | 8.10M |
| Net Income | 7.24M | -2.83M | -13.94M | 98.30M | 185.01M | 8.10M |
Balance Sheet | ||||||
| Total Assets | 654.67M | 680.79M | 753.87M | 817.09M | 765.10M | 505.98M |
| Cash, Cash Equivalents and Short-Term Investments | 158.00K | 2.62M | 271.00K | 143.00K | 2.02M | 1.87M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.95M | 2.09M | 2.65M | 2.52M | 2.19M | 1.78M |
| Stockholders Equity | 652.73M | 678.70M | 751.21M | 814.57M | 762.90M | 504.20M |
Cash Flow | ||||||
| Free Cash Flow | -8.54M | -9.35M | -9.86M | -9.59M | -7.68M | -6.57M |
| Operating Cash Flow | -8.54M | -9.35M | -9.86M | -9.59M | -7.68M | -6.57M |
| Investing Cash Flow | 83.16M | 81.37M | 59.40M | 54.50M | -65.87M | 43.60M |
| Financing Cash Flow | -74.65M | -69.68M | -49.42M | -46.79M | 73.70M | -36.92M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £29.92B | 16.49 | 7.09% | 2.98% | 1.78% | -50.72% | |
71 Outperform | £9.02B | 8.54 | 17.41% | 4.50% | 10.68% | 35.18% | |
69 Neutral | £2.88B | 0.40 | 3.94% | 2.78% | -19.04% | -34.52% | |
67 Neutral | £2.44B | 9.64 | 3.09% | 6.56% | 19.50% | ― | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
58 Neutral | £20.24M | -1.05 | -68.06% | ― | -60.76% | -230.39% | |
45 Neutral | ― | 11.56 | -0.41% | 12.07% | ― | ― |